REFERENCES
- Rigby RJ, Hawley CM. Sclerosing peritonitis: The experience in Australia. Nephrol Dial Transplant. 1998;13:154–159.
- Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int. 1992;12:14–27.
- Haweley CM, Wall DR, Johnson DW Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1995;26:658–661.
- Nakamura S, Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol. 2004;24:502–505.
- Afthentopoulos IE, Passadakis P, Oreopoulos DG, Bargman J. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: One center's experience and review of the literature. Adv Ren Replace Ther. 1998;5:157–167.
- George C, Al-Zwae K, Nair S, Cast JEI. Computed tomography appearances of sclerosing encapsulating peritonitis. Clin Radiol. 2007;62:732–737.
- Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int. 2006;26:203–206.
- Duman S, Bozkurt D, Sipahi S Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model. Adv Perit Dial. 2008;24:104–110.
- Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg. 1990;125:1626–1628.
- Bowers V, Ackerman JR, Richardson R, Carey L. Sclerosing peritonitis. Clin Transplant. 1994;8:369–372.